Imaging Contrast

Contrast agents are injected into patients to help enhance images to make it easier for radiologists distinguish specific areas of the body from surrounding tissues. The most commonly used agents are iodinated contrast dye for computed tomography (CT), interventional cath lab angiography,  RF fluoroscopy, and in surgical OR procedures. MRI scans typically use gadolinium-based contrast agents. Ultrasound and echocardiography (cardiac ultrasound) imaging use contrast agents composed of microscopic bubbles to enhance images that otherwise would be suboptimal.

Thumbnail

How common are acute kidney injuries in kids following contrast administration?

Based on the findings of a new paper in Radiology, the risks of contrast-associated acute kidney injuries are rare in kids, but age can be a protective factor.

AI is still one of the key technologies on the floor many radiologists want to learn more about. of the AI. A product rep discussing breast automated detection AI in the crowded Lunit booth at RSNA 2022.

9 technology trends and takeaways from RSNA 2022

Here are some interesting new technologies and key trends from the vast expo floor at the Radiological Society of North America 2022 meeting.

GE Healthcare program recycles departments' leftover iodinated contrast for future use

In 2006, the company started an iodine recycling program for imaging departments that had leftover contrast that would go to waste at the end of the day if left unused. That program expanded into the U.S. and Canada in 2021.

Thumbnail

GE Healthcare's $80 million investment furthers mission to increase contrast media production

This latest move—one of many made by GE recently—contributes to the company’s goal of upping contrast media production by an additional 30 million doses by the year 2025. 

synthetic contrast-enhanced breast MRI

Are synthetic contrast-enhanced breast MRI images as good as the real thing?

Synthesizing contrast-enhanced imaging from pre-contrast inputs using deep learning can help overcome obstacles involved in the use of GBCAs.

Iodinated contrast use before, during and after COVID: Trends predict significant growth in demand

A new analysis suggests that, if the use of iodinated contrast were to follow pre-pandemic trends, it could rise by as much as 37% from 2019. 

Thumbnail

GE Healthcare set to bolster supply of iodinated contrast media

These moves are part of a broader plan to increase the supply of iodine raw material, eventually enabling the production of an additional 30 million doses of iodinated contrast media annually by the year 2025. 

Thumbnail

Experts share positive news for women who have undergone multiple GBCA exposures during breast MRI

Authors of the new study stated that their findings are “reassuring” for both clinicians and patients.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup